Overview
Rare hemorrhagic disorder due to a constitutional coagulation factors defect is an umbrella term used to describe a group of inherited bleeding conditions caused by problems with one or more of the proteins (called coagulation factors) that help blood clot properly. These conditions are sometimes called 'rare bleeding disorders' or 'rare coagulation factor deficiencies.' Unlike the more well-known hemophilia A and B, these disorders involve deficiencies in other clotting factors such as factor I (fibrinogen), factor II (prothrombin), factor V, factor VII, factor X, factor XI, factor XIII, or combined factor deficiencies. When one or more of these clotting proteins is missing or does not work correctly, the blood cannot form a stable clot after an injury. This means that even minor cuts, dental procedures, or surgeries can lead to prolonged or excessive bleeding. Internal bleeding into joints, muscles, or organs can also occur, sometimes without any obvious injury. Symptoms vary widely depending on which factor is affected and how severe the deficiency is. Some people experience frequent nosebleeds, easy bruising, heavy menstrual periods, or bleeding gums. Others may have more serious episodes such as bleeding into the brain or gastrointestinal tract. Treatment typically involves replacing the missing clotting factor using plasma-derived or recombinant factor concentrates, fresh frozen plasma, or other clotting agents. With proper management, many people with these disorders can live full and active lives.
Also known as:
Key symptoms:
Prolonged or heavy bleeding after cuts, injuries, or surgeryFrequent or hard-to-stop nosebleedsEasy or unexplained bruisingHeavy or prolonged menstrual periods in womenBleeding gums, especially after dental workBleeding into joints causing pain and swellingBleeding into musclesBlood in the urine or stoolProlonged bleeding after childbirthBleeding in the brain (in severe cases)Umbilical cord bleeding in newbornsDelayed wound healingExcessive bleeding after circumcision
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventCSL Behring — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Rare hemorrhagic disorder due to a constitutional coagulation factors defect.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Rare hemorrhagic disorder due to a constitutional coagulation factors defect.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare hemorrhagic disorder due to a constitutional coagulation factors defect.
Community
No community posts yet. Be the first to share your experience with Rare hemorrhagic disorder due to a constitutional coagulation factors defect.
Start the conversation →Latest news about Rare hemorrhagic disorder due to a constitutional coagulation factors defect
No recent news articles for Rare hemorrhagic disorder due to a constitutional coagulation factors defect.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific clotting factor am I deficient in, and how severe is my deficiency?,What treatment options are available for my specific factor deficiency, and should I be on regular preventive therapy?,What should I do — and who should I call — if I have a serious bleeding episode or a head injury?,Are there activities or medications I should avoid to reduce my bleeding risk?,Should other family members be tested, and what are the chances of passing this condition to my children?,How should I prepare for surgery, dental procedures, or pregnancy?,Is there a hemophilia treatment center near me where I can receive specialized ongoing care?
Common questions about Rare hemorrhagic disorder due to a constitutional coagulation factors defect
What is Rare hemorrhagic disorder due to a constitutional coagulation factors defect?
Rare hemorrhagic disorder due to a constitutional coagulation factors defect is an umbrella term used to describe a group of inherited bleeding conditions caused by problems with one or more of the proteins (called coagulation factors) that help blood clot properly. These conditions are sometimes called 'rare bleeding disorders' or 'rare coagulation factor deficiencies.' Unlike the more well-known hemophilia A and B, these disorders involve deficiencies in other clotting factors such as factor I (fibrinogen), factor II (prothrombin), factor V, factor VII, factor X, factor XI, factor XIII, or c
Are there clinical trials for Rare hemorrhagic disorder due to a constitutional coagulation factors defect?
Yes — 1 recruiting clinical trial is currently listed for Rare hemorrhagic disorder due to a constitutional coagulation factors defect on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.